UA95650C2 - Biaryl ether urea compounds, pharmaceutical composition and method for the treatment diseases associated with fatty acid amide hydrolase activity - Google Patents

Biaryl ether urea compounds, pharmaceutical composition and method for the treatment diseases associated with fatty acid amide hydrolase activity

Info

Publication number
UA95650C2
UA95650C2 UAA200903819A UAA200903819A UA95650C2 UA 95650 C2 UA95650 C2 UA 95650C2 UA A200903819 A UAA200903819 A UA A200903819A UA A200903819 A UAA200903819 A UA A200903819A UA 95650 C2 UA95650 C2 UA 95650C2
Authority
UA
Ukraine
Prior art keywords
fatty acid
acid amide
pharmaceutical composition
diseases associated
amide hydrolase
Prior art date
Application number
UAA200903819A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Лоррейн Кетлин Фей
Дуглас Скотт Джонсон
Скотт Эдвард Лейзервиз
Марк Энтони Моррис
Лиджуан Джейн Ванг
Марвин Джей Меерс
Сюзанн Росс Кестен
Кори Майкл Стифф
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of UA95650C2 publication Critical patent/UA95650C2/en

Links

Abstract

The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity., (I)
UAA200903819A 2006-10-18 2007-10-05 Biaryl ether urea compounds, pharmaceutical composition and method for the treatment diseases associated with fatty acid amide hydrolase activity UA95650C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82996606P 2006-10-18 2006-10-18

Publications (1)

Publication Number Publication Date
UA95650C2 true UA95650C2 (en) 2011-08-25

Family

ID=50836655

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200903819A UA95650C2 (en) 2006-10-18 2007-10-05 Biaryl ether urea compounds, pharmaceutical composition and method for the treatment diseases associated with fatty acid amide hydrolase activity

Country Status (1)

Country Link
UA (1) UA95650C2 (en)

Similar Documents

Publication Publication Date Title
MX2009004233A (en) Biaryl ether urea compounds.
WO2010021680A3 (en) Inhibitors of beta-secretase
TW200740801A (en) N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
NZ619076A (en) Isoxazolines as inhibitors of fatty acid amide hydrolase
HK1138840A1 (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
PH12012500765A1 (en) Boronic acids and esters as inhibitors of fatty acid amide hydrolase
MY146662A (en) Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
MX2015003653A (en) Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators.
MY142589A (en) Benzimidazole derivatives : preparation and pharmaceutical applications
TW200745122A (en) New compounds I
MX2012006490A (en) Azocyclic inhibitors of fatty acid amide hydrolase.
TW200738653A (en) Anthranilamide/2-amino-heteroarene carboxamide derivatives
TW200745097A (en) 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors
EP2091328A4 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
TNSN07435A1 (en) Novel piperidine carboxylic acid amide derivatives
UA86441C2 (en) (2-hydroxyethyl)trimethylammonium thiooctate (choline thioctate), having hepatoprotective, hypoamoniemic and detoxic action, method for production thereof and pharmaceutical compositions based on it
TW200738714A (en) New secondary amines
UA96794C2 (en) Glucocorticoides, method of use thereof, treatment method and pharmaceutical formulation based thereon
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
MXPA05010020A (en) Oxamide derivatives useful as raf-kinase inhibitors.
TW200800940A (en) New primary amines
TW200745133A (en) New compounds II
MY179041A (en) Crystalline forms of a 3-carboxypropyl-aminotetralin compound
UA94042C2 (en) Use of agomelatine for the preparation of drugs to treat smith magenis syndrome
UA95650C2 (en) Biaryl ether urea compounds, pharmaceutical composition and method for the treatment diseases associated with fatty acid amide hydrolase activity